Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00738478
Recruitment Status : Completed
First Posted : August 20, 2008
Last Update Posted : February 18, 2009
Information provided by:
Wakayama Medical University

Brief Summary:
The aim of the study is to evaluate whether distal gastrectomy without post-operative nasogastric decompression tube is better in terms of quality of life.

Condition or disease Intervention/treatment Phase
Gastric Cancer Device: nasogastric tube Device: without nasogastric tube Phase 3

Detailed Description:
Nasogastric decompression tube is an intra-operative routine in most of the time to facilitate exposure of operative field during elective distal gastrectomy, however, whether it should be retained post-operatively is controversial. Nasogastric decompression tube helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. However, nasogastric intubation could cause patients discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with pulmonary complication.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 180 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients
Study Start Date : February 2006
Actual Primary Completion Date : December 2008
Actual Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stomach Cancer
U.S. FDA Resources

Arm Intervention/treatment
Experimental: A
Arm A: with nasogastric tube
Device: nasogastric tube
insertion of nasogastric tube for 2 days after operation
Active Comparator: B
Arm B: without nasogastric tube
Device: without nasogastric tube
without nasogastric tube after operation

Primary Outcome Measures :
  1. Quality of life [ Time Frame: seven days after operation ]

Secondary Outcome Measures :
  1. complication, hematological data, [ Time Frame: the time of discharge ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • on the basis of whether distal gastrectomy was anticipated at WMUH for gastric cancer.

Exclusion Criteria:

  • patients who were diagnosed inadequacy for this study by a physician.
  • patients without an informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00738478

Second Department of Surgery, Wakayama Medical University
Wakayama, Japan, 641-8510
Sponsors and Collaborators
Wakayama Medical University
Principal Investigator: Mikihito Nakamori, MD Wakayama Medical University

Responsible Party: Second Department of Surgery, Wakayama Medical University Identifier: NCT00738478     History of Changes
Other Study ID Numbers: WMC-RCTGastric01
First Posted: August 20, 2008    Key Record Dates
Last Update Posted: February 18, 2009
Last Verified: February 2009

Keywords provided by Wakayama Medical University:
distal gastrectomy
quality of life

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases